Vicarious Surgical (RBOT) EPS (Basic) (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly EPS (Basic) came in at -$1.86 in Q3 2025, up 35.89% year-on-year from -$1.37 in Q3 2024, and up 16.55% on a QoQ basis from -$2.23 in Q2 2025.
Vicarious Surgical (RBOT) EPS (Basic) (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of EPS (Basic) data on file, last reported at -$1.86 in Q3 2025.
- On a quarterly basis, EPS (Basic) rose 35.89% year-over-year to -$1.86 in Q3 2025; TTM through Dec 2025 was -$6.66, a 37.98% increase from a year earlier, with the FY2024 full-year figure at -$10.74, up 26.45% from the prior year.
- EPS (Basic) for Q3 2025 stood at -$1.86, up from -$2.23 in the prior quarter.
- Over the last five years, EPS (Basic) for RBOT reached as high as $16.48 in Q4 2021 and fell as low as -$34.34 in Q3 2021.
- Historically, EPS (Basic) has averaged -$2.86 across 5 years, with a median of -$2.6 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 861.53% in 2021 and fell as far as 2022.37% in 2021.
- Year by year, EPS (Basic) stood at $16.48 in 2021, then slumped by 116.71% to -$2.75 in 2022, then rose by 2.18% to -$2.69 in 2023, then increased by 12.18% to -$2.37 in 2024, then advanced by 21.51% to -$1.86 in 2025.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.86 in Q3 2025, -$2.23 in Q2 2025, and -$2.6 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.86 |
| Jun 30, 2025 | -2.23 |
| Mar 31, 2025 | -2.60 |
| Dec 31, 2024 | -2.37 |
| Sep 30, 2024 | -2.90 |
| Jun 30, 2024 | -2.59 |
| Mar 31, 2024 | -2.90 |
| Dec 31, 2023 | -2.69 |
| Sep 30, 2023 | -3.04 |
| Jun 30, 2023 | -3.62 |
| Mar 31, 2023 | -6.40 |
| Dec 31, 2022 | -2.75 |
| Sep 30, 2022 | -6.09 |
| Jun 30, 2022 | -0.36 |
| Mar 31, 2022 | 10.00 |
| Dec 31, 2021 | 16.48 |
| Sep 30, 2021 | -34.34 |
| Jun 30, 2021 | -2.27 |
| Mar 31, 2021 | -1.79 |
| Dec 31, 2020 | -2.16 |